GLP-1 patches are nonsense. Here is the science of why.

Reason one: skin does not let molecules this size through

Transdermal patches are real medicine; nicotine and HRT patches work because their active molecules are tiny. The rule of thumb in drug delivery is that molecules under about 500 daltons can cross the skin barrier. Semaglutide weighs around 4,113 daltons. Tirzepatide is bigger still. That is eight times over the limit, like trying to post a sofa through a letterbox. This is not a formulation problem waiting for a clever startup to solve it. It is a wall of basic biophysics, and it is why Novo Nordisk and Eli Lilly, with billions in research budgets, deliver these drugs by injection or by a specially engineered tablet, never through skin.

Reason two: no GLP-1 patch is licensed anywhere on Earth

Every genuine GLP-1 medicine is a prescription-only product with a public licence you can look up. The MHRA has licensed Mounjaro, the Wegovy injection and, since 11 June 2026, Wegovy pills. No regulator in any country has licensed a GLP-1 patch. That leaves only two possibilities for what is being sold online. Either the patch contains no meaningful GLP-1 drug at all, in which case it is an expensive plaster. Or it somehow does contain the drug, in which case it is an unlicensed medicine and selling it is a criminal offence in the UK. There is no third option.

Reason three: "natural GLP-1 boosters" are marketing poetry

The second wave of products does not claim to contain the drug. Instead they promise to "boost your own GLP-1 naturally" with berberine, chromium or plant extracts. Two problems. First, even swallowed, none of these ingredients raises GLP-1 anywhere near the levels the real medicines produce; the honest human-trial results are tiny at best. Second, the doses in a patch are a fraction of the already-questionable doses in pills, and there is no good evidence these compounds absorb through skin at all. You are buying a sticker with a story attached.

The red flags, in one place

• Sold through social media ads, influencers or messaging apps. Genuine GLP-1 medicines are never marketed this way. Ever.
• Words like "supports", "mimics" or "boosts your own". Legal-weasel language that means "contains nothing that works like the drug".
• No named UK pharmacy, no GPhC registration number, no prescriber. The three things every legitimate supply route has.
• Before-and-after photos and countdown timers. Real medicine does not need theatre.
• Claims a patch works as well as injections. Physically impossible, as covered above.
• "New pill available early" offers. Foundayo (orforglipron) is approved in the US but not licensed in the UK, and retatrutide is still in clinical trials. Any UK site selling either, in any packaging, is selling an unlicensed or fake product.

If you have bought one of these products and had a reaction, report it through the MHRA Yellow Card scheme. If you see them advertised, you can report the advert to the ASA, and the sale itself to the MHRA, which actively investigates illegal medicine sellers.

What to do instead

If you want GLP-1 treatment without injections, the genuine option now exists: the Wegovy pill, a daily 25 mg tablet licensed by the MHRA in June 2026, which produced 13.6% average weight loss in its main trial. If injections do not bother you, Mounjaro and the Wegovy pen have the strongest results of all. Whichever route fits you, go through a proper clinical assessment and a GPhC-registered pharmacy, and check the pharmacy's score at pharmacy-score.co.uk before you part with money. The checked lists at monj.co.uk (Mounjaro), igovy.co.uk (Wegovy injection) and ogovy.co.uk (Wegovy pills) exist precisely so you never have to gamble on a patch, a gummy or a stranger on the internet. Our medication guide walks through the whole decision.